Skip to main content

Bruker, Nanosys Ink R&D and Marketing Pact for NALDI Chip/Mass Spec Apps

NEW YORK (GenomeWeb News) - Nanosys and Bruker Daltonics have entered a research and development and distribution agreement that will couple Nanosys' NALDI target plates with Bruker's mass spectrometers, Bruker said today.
 
Under the agreement, Nanosys will supply Bruker with its nanotechnology-enabled matrix-free target plates, called NALDI chips, which Bruker will market with its laser desorption ionization time-of-flight mass spectrometers. Bruker will distribute the chips through its international marketing networks.
 
Bruker said that NALDI chips enable sensitive analysis of drug compounds, small peptides, natural products, pesticides and other low-mass molecules that are otherwise difficult to analyze with mass spec.
 
The companies will collaborate on assay development for molecular research and imaging, pharmaceutical development, and analysis for food, environmental and toxicological research.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.